Nvidia Stock: Near All-Tim High Yet Indicators Are Mixed — All Eyes On 2024
Nvidia's stock technicals look bullish. Bearish divergence on OBV suggests caution, but fwd P/E is not too expensive compared to peers.
ConocoPhillips’ Willow Project: Green Light for Alaskan Energy Boost Amid Controversy
On Friday, ConocoPhillips (NYSE: COP) disclosed that it is moving forward with developing
AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies
AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Gracell Biotechnologies Inc (NASDAQ: GRCL), further strengthening AstraZeneca's cell therapy portfolio.
Benzinga Bulls And Bear: Apple, Tesla, Ethereum And Analyst Details Conditions For Dogecoin’s ‘Gorgeous Pump’ This Christmas
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
EXCLUSIVE: Find Value In Large Multinationals And Catch The Dividend Yield, Says Tim Seymour
Tim Seymour says the Federal Reserve is cutting rates for a reason - stalling growth.
Cathie Wood Predicts Deflation In 2024, More AI And Tech Optimism — And Rate Cuts
Cathie Wood believes deflation in 2024, aggressive rate cuts and technological progress will drive expansion.
VICI’s Strategic Diversification And GLPI’s Future Acquisitions: Goldman Sachs Weighs Investor Sentiments
Goldman Sachs analyst Caitlin Burrows disclosed investor feedback related to both VICI Properties Inc (NYSE: VICI) and Gaming and Leisure Properties Inc (NASDAQ:
S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed’s Inflation Gauge Cools: What’s Driving Markets Friday?
The S&P 500 and Nasdaq 100 indices are on the verge of achieving an impressive eight consecutive weeks of gains following a more significant decline than expected in the Federal Reserve’s favored inflation gauge in November, the Personal Consumption Expenditures
Is Lower Inflation A Green Light For 2024 Interest Rate Cuts? Markets Are Ending The Year ‘Surprised,’ CIO Says
The Personal Consumption Expenditures (PCE) index inflation dropped to its lowest since March 2021, with economists weighing in on Fed's strategy for rate reductions in 2024.,The market continued to demonstrate resilience, with the SPDR S&P 500 ETF Trust (ARCA: SPY) experiencing a slight uptick, rising by 0.3%.
With Karuna Therapeutics $14B Deal, Bristol Myers Is Serious For Re-Establishing Its Neurology Portfolio: Analyst
Earlier Friday, Bristol Myers Squibb & Co (NYSE: BMY) agreed to acquire Karuna Therapeutics Inc (NASDAQ: KRTX) for $330.00 per share in cash, for a total equity value of $14.0 billion, or $12.7 bill